Search Results - "Lafont, O."

Refine Results
  1. 1

    Terahertz emission from multiple-microcavity exciton-polariton lasers by Huppert, S., Lafont, O., Baudin, E., Tignon, J., Ferreira, R.

    “…Terahertz emission between exciton-polariton branches in semiconductor microcavities is expected to be strongly stimulated in the polariton laser regime due to…”
    Get full text
    Journal Article
  2. 2

    Controlling the optical spin Hall effect with light by Lafont, O., Luk, S. M. H., Lewandowski, P., Kwong, N. H., Leung, P. T., Galopin, E., Lemaitre, A., Tignon, J., Schumacher, S., Baudin, E., Binder, R.

    Published in Applied physics letters (06-02-2017)
    “…The optical spin Hall effect is a transport phenomenon of exciton polaritons in semiconductor microcavities, caused by the polaritonic spin-orbit interaction,…”
    Get full text
    Journal Article
  3. 3

    Functionalized cyclodextrins bearing an alpha nucleophile – A promising way to degrade nerve agents by Estour, F., Letort, S., Müller, S., Kalakuntla, R.K., Le Provost, R., Wille, T., Reiter, G., Worek, F., Lafont, O., Gouhier, G.

    Published in Chemico-biological interactions (25-03-2013)
    “…Organophosphorus nerve agents are irreversible inhibitors of acetylcholinesterase. Current treatment of nerve agent poisoning has limited efficacy and more…”
    Get full text
    Journal Article
  4. 4

    Detoxification of nerve agents by a substituted β-cyclodextrin: Application of a modified biological assay by Wille, T, Tenberken, O, Reiter, G, Müller, S, Le Provost, R, Lafont, O, Estour, F, Thiermann, H, Worek, F

    Published in Toxicology (Amsterdam) (30-11-2009)
    “…Abstract Chemical warfare agents (nerve agents) are still available and present a real threat to the population. Numerous in vitro and in vivo studies showed…”
    Get full text
    Journal Article
  5. 5

    The origins of analysis and of drugs control by Lafont, O

    Published in Annales pharmaceutiques françaises (01-07-2017)
    “…Analytical concerns were quite ancient. As soon as the 12th century, Al-Chayzari searched drugs falsifications. During the 17th century, retort analysis was…”
    Get more information
    Journal Article
  6. 6

    Primidone-loaded poly-ε-caprolactone nanocapsules: incorporation efficiency and in vitro release profiles by Ferranti, V, Marchais, H, Chabenat, C, Orecchioni, A.M, Lafont, O

    Published in International journal of pharmaceutics (20-12-1999)
    “…This paper describes the preparation of primidone-loaded poly-ε-caprolactone nanocapsules according to the interfacial deposition technique. The colloidal…”
    Get full text
    Journal Article
  7. 7

    Aminoglutethimide included in nanocapsules suspension: comparison of GC–MS and HPLC methods for control by Berrabah, M, Andre, D, Verite, P, Zahidi, A, Lafont, O

    “…Gas chromatography–mass spectrometry (GC–MS) and high performance liquid chromatography (HPLC) offer highly efficient and potentially sensitive separation and…”
    Get full text
    Journal Article
  8. 8

    Vauquelin: route from a thatched cottage to Institute of France by Lafont, O

    Published in Annales pharmaceutiques françaises (01-07-2014)
    “…Nicolas Louis Vauquelin was born in a little thatched cottage in Saint-André-d'Hébertot, in Normandy, on May 16th 1763. He went to Rouen and then to Paris…”
    Get more information
    Journal Article
  9. 9

    Parmentier hygiene and public health by Lafont, O

    Published in Annales pharmaceutiques françaises (01-05-2014)
    “…The legend about Parmentier is quite reductive when it limits his activity to the promotion of potato. This military pharmacist intended mainly to make science…”
    Get more information
    Journal Article
  10. 10

    Improvement of Synthetic Pathways to Thalidomide Ester Derivatives by Lafont, Olivier, Mansard, Gaël, Estour, François, Galons, Hervé

    Published in Heterocycles (01-12-2005)
    “…Three synthetic approaches to N-substituted Thalidomide prodrugs from (S)-phtaloylglutamic acid, (S)-Boc-glutamic acid or phtaloylglutamic anhydride are…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Entrapment Efficiency and Initial Release of Phenylbutazone from Nanocapsules Prepared from Different Polyesters by Marchais, H., Benali, S., Irache, J. M., Tharasse-Bloch, C., Lafont, O., Orecchioni, A. M.

    Published in Drug development and industrial pharmacy (01-01-1998)
    “…Abstract Several formulations of poly( -caprolactone) (PCL), poly(lactic acid) (PLA), and poly(lactic-co-glycolic acid) (PLGA) nanocapsules containing…”
    Get full text
    Journal Article
  13. 13

    From apprenticeship to Nobel Prize: Henri Moissan's fabulous destiny by Lafont, O

    Published in Annales pharmaceutiques françaises (01-01-2008)
    “…Born in Paris on September 28, 1852, son of an eastern railways' employee and of a dressmaker, Henri Moissan's secondary schooling in Meaux did not allow him…”
    Get more information
    Journal Article
  14. 14

    Pharmacokinetics of pyrazinamide and its metabolites in healthy subjects by LACROIX, C, PHAN HOANG, T, NOUVEAU, J, GUYONNAUD, C, LAINE, G, DUWOOS, H, LAFONT, O

    Published in European journal of clinical pharmacology (01-01-1989)
    “…The plasma and urine pharmacokinetic parameters of pyrazinamide and of its metabolites (pyrazinoic acid, 5-hydroxy-pyrazinamide, 5-hydroxy-pyrazinoic acid and…”
    Get full text
    Journal Article
  15. 15

    Interaction between allopurinol and pyrazinamide by Lacroix, C, Guyonnaud, C, Chaou, M, Duwoos, H, Lafont, O

    Published in The European respiratory journal (01-10-1988)
    “…Pyrazinamide (PZA) is increasingly used with isoniazid and rifampicin, in short-course antituberculous chemotherapy in service programme conditions…”
    Get more information
    Journal Article
  16. 16

    Determination of Progesterone in Nanocapsules by High Performance Liquid Chromatography by Benali, S., Tharasse-Bloch, C., André, D., Vérité, P., Duclos, R., Lafont, O.

    “…In order to determine progesterone concentration in nanocapsules consisting of benzyl benzoate in a poly-ϵ-caprolactone shell, various methods were tested for…”
    Get full text
    Journal Article
  17. 17

    GC-MS determination of phenobarbitone entrapped in poly-epsilon-caprolactone nanocapsules by Berrabah, M, André, D, Prévot, F, Orecchioni, A M, Lafont, O

    “…In order to evaluate the concentration of a hydrophilic drug, phenobarbitone, in a suspension of poly-epsilon-caprolactone nanocapsules, a gas…”
    Get more information
    Journal Article
  18. 18

    Chemical oxidation of an anticonvulsant N-(5′-methylisoxazol-3-yl)-2,6-dimethylbenzamide (D2916) by Adolphe-Pierre, S., Ménager, S., Tombret, F., Vérité, Ph, Lepage, F., Lafont, O.

    Published in Farmaco (Società chimica italiana : 1989) (30-07-1998)
    “…The new anticonvulsant N-(5′-methylisoxazol-3-yl)-2,6-dimethylbenzamide (D2916), which presents two kinds of methyl groups which could be oxidized, was…”
    Get full text
    Journal Article
  19. 19

    Competition between two metabolic pathways: oxidation and desulfuration in the thiobarbiturate series by Yebga, A, Ménager, S, Vérité, P, Farnoux, C Combet, Lafont, O

    “…In order to study the competition between hepatic hydroxylation and desulfuration in the thiobarbiturate series, two compounds bearing a branched side chain…”
    Get full text
    Journal Article
  20. 20

    Detoxification of nerve agents by a substituted b-cyclodextrin: Application of a modified biological assay by Wille, T, Tenberken, O, Reiter, G, Muller, S, Le Provost, R, Lafont, O, Estour, F, Thiermann, H, Worek, F

    Published in Toxicology (Amsterdam) (30-11-2009)
    “…Chemical warfare agents (nerve agents) are still available and present a real threat to the population. Numerous in vitro and in vivo studies showed that…”
    Get full text
    Journal Article